-
1
-
-
50549167392
-
Pulmonary embolism
-
Jordan WM. Pulmonary embolism. Lancet 1961; 2: 1146-7.
-
(1961)
Lancet
, vol.2
, pp. 1146-1147
-
-
Jordan, W.M.1
-
2
-
-
0014962032
-
Thromboembolic disease and the steroidal content of oral contraceptives a report to the committee on safety of drugs
-
Inman WHW, Vessey MP, Westerholm B, Engelund A, Thromboembolic disease and the steroidal content of oral contraceptives a report to the committee on safety of drugs. British Medical Journal 1970; 2: 203-9.
-
(1970)
British Medical Journal
, vol.2
, pp. 203-209
-
-
Inman, W.H.W.1
Vessey, M.P.2
Westerholm, B.3
Engelund, A.4
-
3
-
-
0023904587
-
Risks and mechanism of cardiovascular events in users of oral contraceptives
-
Meade TW. Risks and mechanism of cardiovascular events in users of oral contraceptives. Am J Obstet Gynecol 1988; 158: 1646-52.
-
(1988)
Am J Obstet Gynecol
, vol.158
, pp. 1646-1652
-
-
Meade, T.W.1
-
4
-
-
0026078062
-
Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease
-
Gerstman BB, Piper JM, Tomita DK, Frerguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. American Journal of Epidemiology 1991; 133: 32-7.
-
(1991)
American Journal of Epidemiology
, vol.133
, pp. 32-37
-
-
Gerstman, B.B.1
Piper, J.M.2
Tomita, D.K.3
Frerguson, W.J.4
Stadel, B.V.5
Lundin, F.E.6
-
5
-
-
0002961445
-
Evidence that currently available pills are associated with cardiovascular disease: Venous disease
-
Hannaford PC, Webb AMC. (Carnforth, UK: Parthenon Publishing)
-
Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Evidence that currently available pills are associated with cardiovascular disease: venous disease. In: Hannaford PC, Webb AMC. Evidence-guided Prescribing of the Pill 1996: 61-76 (Carnforth, UK: Parthenon Publishing).
-
(1996)
Evidence-guided Prescribing of the Pill
, pp. 61-76
-
-
Bloemenkamp, K.W.M.1
Rosendaal, F.R.2
Helmerhorst, F.M.3
Vandenbroucke, J.P.4
-
6
-
-
0029564931
-
Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
-
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. Lancet 1995; 346: 1575-82.
-
(1995)
Lancet
, vol.346
, pp. 1575-1582
-
-
-
7
-
-
13344260005
-
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
-
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-8.
-
(1995)
Lancet
, vol.346
, pp. 1582-1588
-
-
-
8
-
-
0029586002
-
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
-
Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-93.
-
(1995)
Lancet
, vol.346
, pp. 1589-1593
-
-
Jick, H.1
Jick, S.S.2
Gurewich, V.3
Myers, M.W.4
Vasilakis, C.5
-
9
-
-
0029609256
-
Enhancement by factor V Leiden mutation of risk of deepvein thrombosis associated with oral contraceptives containing third-generation progestagen
-
Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deepvein thrombosis associated with oral contraceptives containing third-generation progestagen. Lancet 1995; 346: 1593-6.
-
(1995)
Lancet
, vol.346
, pp. 1593-1596
-
-
Bloemenkamp, K.W.M.1
Rosendaal, F.R.2
Helmerhorst, F.M.3
Buller, H.R.4
Vandenbroucke, J.P.5
-
10
-
-
0029671042
-
Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
-
Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996; 312: 83-8.
-
(1996)
BMJ
, vol.312
, pp. 83-88
-
-
Spitzer, W.O.1
Lewis, M.A.2
Heinemann, L.A.J.3
Thorogood, M.4
MacRae, K.D.5
-
11
-
-
0000549495
-
Pathogenesis of venous thrombosis
-
Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds). New York: Churchill-Livingstone
-
Thomas DP. Pathogenesis of venous thrombosis. In: Haemostasis and Thrombosis, 3rd edition. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds). New York: Churchill-Livingstone 1994; pp. 1335-47.
-
(1994)
Haemostasis and Thrombosis, 3rd Edition
, pp. 1335-1347
-
-
Thomas, D.P.1
-
12
-
-
0002596183
-
Epidemiology of pulmonary embolism and deep venous thrombosis
-
Bloom AL, Forbes CD, Thomas DP, Tuddenham HGD (eds). New York: ChurchillLivingstone
-
Goldhaber SZ. Epidemiology of pulmonary embolism and deep venous thrombosis. In: Haemostasis and Thrombosis. 3rd edition. Bloom AL, Forbes CD, Thomas DP, Tuddenham HGD (eds). New York: ChurchillLivingstone 1994; pp. 1327-33.
-
(1994)
Haemostasis and Thrombosis. 3rd Edition
, pp. 1327-1333
-
-
Goldhaber, S.Z.1
-
13
-
-
0028213422
-
New progestogens in oral contraception
-
Fotherby K, Caldwell ADS. New progestogens in oral contraception. Contraception 1994; 49: 1-32.
-
(1994)
Contraception
, vol.49
, pp. 1-32
-
-
Fotherby, K.1
Caldwell, A.D.S.2
-
14
-
-
0028116025
-
Low-dose combined oral contraceptives
-
Robinson GE. Low-dose combined oral contraceptives. British J Obstet and Gynaecol 1994; 101: 1036-42.
-
(1994)
British J Obstet and Gynaecol
, vol.101
, pp. 1036-1042
-
-
Robinson, G.E.1
-
15
-
-
0021885167
-
Effects of oral contraceptives on blood coagulation. A review
-
Beller FK, Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstetrical and Gynecological Survey 1985; 40: 425-36.
-
(1985)
Obstetrical and Gynecological Survey
, vol.40
, pp. 425-436
-
-
Beller, F.K.1
Ebert, C.2
-
16
-
-
0030756915
-
Effect of oral contraceptives on haemostasis variables
-
Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997; 78: 315-26.
-
(1997)
Thromb Haemost
, vol.78
, pp. 315-326
-
-
Kluft, C.1
Lansink, M.2
-
17
-
-
0020040466
-
Oral contraceptives and blood coagulation: A critical review
-
Mammen EF. Oral contraceptives and blood coagulation: a critical review. Am J Obstet Gynecol 1982; 142: 781-90.
-
(1982)
Am J Obstet Gynecol
, vol.142
, pp. 781-790
-
-
Mammen, E.F.1
-
18
-
-
0020054168
-
Oral contraceptives, clotting factors, and thrombosis
-
Meade TW. Oral contraceptives, clotting factors, and thrombosis. Am J Obstet Gynecol 1982; 142: 758-61.
-
(1982)
Am J Obstet Gynecol
, vol.142
, pp. 758-761
-
-
Meade, T.W.1
-
19
-
-
0026664240
-
Estrogen-associated thromboembolism
-
Wessler S. Estrogen-associated thromboembolism. Ann Epidemiol 1992; 2: 439-43.
-
(1992)
Ann Epidemiol
, vol.2
, pp. 439-443
-
-
Wessler, S.1
-
20
-
-
0028314865
-
Mutation in blood coagulation factor V associated with resistance to activated protein C
-
Bertina RM, Koeleman RPC. Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
-
(1994)
Nature
, vol.369
, pp. 64-67
-
-
Bertina, R.M.1
Koeleman, R.P.C.2
Koster, T.3
Rosendaal, F.R.4
Dirven, R.J.5
De Ronde, H.6
Van Der Velden, P.A.7
Reitsma, P.H.8
-
21
-
-
0028931717
-
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
-
see comments
-
Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [see comments]. Blood 1995; 85: 1504-8.
-
(1995)
Blood
, vol.85
, pp. 1504-1508
-
-
Rosendaal, F.R.1
Koster, T.2
Vandenbroucke, J.P.3
Reitsma, P.H.4
-
22
-
-
0028029477
-
Inceased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
-
Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Inceased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 334: 1453-7.
-
(1994)
Lancet
, vol.334
, pp. 1453-1457
-
-
Vandenbroucke, J.P.1
Koster, T.2
Briët, E.3
Reitsma, P.H.4
Bertina, R.M.5
Rosendaal, F.R.6
-
23
-
-
0028239952
-
Syndromes of hypercoagulability and Thrombosis: A review
-
Bick RL, Pegram M. Syndromes of hypercoagulability and Thrombosis: a review. Seminars in Thrombosis and Hemostasis 1994; 20 (1): 109-32.
-
(1994)
Seminars in Thrombosis and Hemostasis
, vol.20
, Issue.1
, pp. 109-132
-
-
Bick, R.L.1
Pegram, M.2
-
24
-
-
0026231412
-
The role of drugs, paticularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: A studs of six patients
-
Girolami A, Simioni P, Girolami B, Zanardi S. The role of drugs, paticularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: a studs of six patients. Blood Coagulation and Fibrinolysis 1991; 2: 673-8.
-
(1991)
Blood Coagulation and Fibrinolysis
, vol.2
, pp. 673-678
-
-
Girolami, A.1
Simioni, P.2
Girolami, B.3
Zanardi, S.4
-
25
-
-
0026519717
-
Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomatic
-
Girolami A, Simioni P, Sartori MT, Zanardi S, Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomatic [letter]. Blood Coagul Fibrinolysis 1992; 3: 119-20.
-
(1992)
Blood Coagul Fibrinolysis
, vol.3
, pp. 119-120
-
-
Girolami, A.1
Simioni, P.2
Sartori, M.T.3
Zanardi, S.4
-
26
-
-
0028324624
-
Thrombotic risk of women with hereditary anlithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors
-
Pabinger I, Schneider B. Thrombotic risk of women with hereditary anlithrombin III-, protein C-and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors. Thromb Haemost 1994; 71: 548-52.
-
(1994)
Thromb Haemost
, vol.71
, pp. 548-552
-
-
Pabinger, I.1
Schneider, B.2
-
27
-
-
0026667740
-
Recent advances in understanding clotting and evaluating patients with recurrent thrombosis
-
Alving BM, Comp PC. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol 1992; 167: 1184-91.
-
(1992)
Am J Obstet Gynecol
, vol.167
, pp. 1184-1191
-
-
Alving, B.M.1
Comp, P.C.2
-
28
-
-
0027520285
-
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
-
Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
-
(1993)
Lancet
, vol.342
, pp. 1503-1506
-
-
Koster, T.1
Rosendaal, F.R.2
De Ronde, H.3
Briët, E.4
Vandenbroucke, J.P.5
Bertina, R.M.6
-
29
-
-
0029033740
-
Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
-
Koster T, Rosendaal FR, Briët E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85: 2756-61.
-
(1995)
Blood
, vol.85
, pp. 2756-2761
-
-
Koster, T.1
Rosendaal, F.R.2
Briët, E.3
Van Der Meer, F.J.M.4
Colly, L.P.5
Trienekens, P.H.6
Poort, S.R.7
Vandenbroucke, J.P.8
-
30
-
-
0028342850
-
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms, Leiden thrombophilia Study
-
Koster T, Rosendaal FR, Reitsma PH, Van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms, Leiden thrombophilia Study. Thromb Haemost 1994; 71: 719-22.
-
(1994)
Thromb Haemost
, vol.71
, pp. 719-722
-
-
Koster, T.1
Rosendaal, F.R.2
Reitsma, P.H.3
Van Der Velden, P.A.4
Briët, E.5
Vandenbroucke, J.P.6
-
31
-
-
0028814316
-
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
-
Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
-
(1995)
Lancet
, vol.345
, pp. 152-155
-
-
Koster, T.1
Blann, A.D.2
Briët, E.3
Vandenbroucke, J.P.4
Rosendaal, F.R.5
-
33
-
-
0028651903
-
Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the devlopment of diagnostic criteria
-
De Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the devlopment of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
-
(1994)
Thromb Haemost
, vol.72
, pp. 880-886
-
-
De Ronde, H.1
Bertina, R.M.2
-
34
-
-
0029909078
-
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contra-ceptives
-
Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contra-ceptives. Thromb Haemost 1996; 76 (5): 729-34.
-
(1996)
Thromb Haemost
, vol.76
, Issue.5
, pp. 729-734
-
-
Quehenberger, P.1
Loner, U.2
Kapiotis, S.3
Handler, S.4
Schneider, B.5
Huber, J.6
Speiser, W.7
-
35
-
-
0027199437
-
Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 μg to 20 μg in oral contraceptives containing desogestrel
-
Basdevant A, Conard J, Pelissier C, Guyene TT, Lapousterle C, Mayer M, Gran BG, Degrelle H. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 μg to 20 μg in oral contraceptives containing desogestrel. Contraception 1993; 48: 193-204.
-
(1993)
Contraception
, vol.48
, pp. 193-204
-
-
Basdevant, A.1
Conard, J.2
Pelissier, C.3
Guyene, T.T.4
Lapousterle, C.5
Mayer, M.6
Gran, B.G.7
Degrelle, H.8
-
36
-
-
0023906144
-
The effects of oestrogenadministration on the plasma free protein S and C4-b-binding protein
-
Melissari E, Kakkar VV. The effects of oestrogenadministration on the plasma free protein S and C4-b-binding protein. Thromb Res 1988; 49: 489-95.
-
(1988)
Thromb Res
, vol.49
, pp. 489-495
-
-
Melissari, E.1
Kakkar, V.V.2
-
37
-
-
0020026065
-
The coagulation and fibrinolytic system in pregnancy and in the puerperium
-
Bellere FK, Ebert CH. The coagulation and fibrinolytic system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol 1982; 13: 177-97.
-
(1982)
Eur J Obstet Gynecol Reprod Biol
, vol.13
, pp. 177-197
-
-
Bellere, F.K.1
Ebert, C.H.2
-
38
-
-
0027465837
-
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
-
Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-8.
-
(1993)
Lancet
, vol.341
, pp. 134-138
-
-
Allaart, C.F.1
Poort, S.R.2
Rosendaal, F.R.3
Reitsma, P.H.4
Bertina, R.M.5
Briët, E.6
-
39
-
-
0030021994
-
A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol
-
Winkler UH, Schindler AE, Endrikat J, Dusterberg B. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol. Contraception 1996; 53: 75-84.
-
(1996)
Contraception
, vol.53
, pp. 75-84
-
-
Winkler, U.H.1
Schindler, A.E.2
Endrikat, J.3
Dusterberg, B.4
-
40
-
-
0027461705
-
Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women
-
Petersen KR, Sidelmann J, Skouby SO, Jespersen J. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women. Am J Obstet Gynecol 1993; 168: 32-8.
-
(1993)
Am J Obstet Gynecol
, vol.168
, pp. 32-38
-
-
Petersen, K.R.1
Sidelmann, J.2
Skouby, S.O.3
Jespersen, J.4
-
41
-
-
0025164622
-
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
-
Jespersen J, Petersen KR, Skouby SO. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am J Obstet Gynecol 1990; 163: 396-403.
-
(1990)
Am J Obstet Gynecol
, vol.163
, pp. 396-403
-
-
Jespersen, J.1
Petersen, K.R.2
Skouby, S.O.3
-
42
-
-
0028033324
-
Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive
-
Cachrimanidou A-C, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception 1994; 50: 153-65.
-
(1994)
Contraception
, vol.50
, pp. 153-165
-
-
Cachrimanidou, A.-C.1
Hellberg, D.2
Nilsson, S.3
Von Schoulz, B.4
Crona, N.5
Siegbahn, A.6
-
43
-
-
0028902902
-
Sensitivity to activated protein C; Influence of oral contraceptoives and sex
-
Henkens CMA, Bom VJJ, Seinen AJ, Meer van der J. Sensitivity to activated protein C; Influence of oral contraceptoives and sex. Thromb Haemost 1995; 73 (3): 402-4.
-
(1995)
Thromb Haemost
, vol.73
, Issue.3
, pp. 402-404
-
-
Henkens, C.M.A.1
Bom, V.J.J.2
Seinen, A.J.3
Meer Van Der, J.4
-
45
-
-
0028886757
-
Resistance to activated protein C in healthy women taking oral contraceptives
-
Olivieri O, Friso S, Manzato F, Guella A, Bernardi F, Lunghi B, et al. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol 1995; 91: 465-70.
-
(1995)
Br J Haematol
, vol.91
, pp. 465-470
-
-
Olivieri, O.1
Friso, S.2
Manzato, F.3
Guella, A.4
Bernardi, F.5
Lunghi, B.6
-
46
-
-
0029372160
-
Thrombotic risk factors and oral contraception
-
Bokarewa MI, Falk G, Sten-Linder M, Egberg N, Blomback M, Bremme K. Thrombotic risk factors and oral contraception. J Lab Clin Med 1995; 126: 294-8.
-
(1995)
J Lab Clin Med
, vol.126
, pp. 294-298
-
-
Bokarewa, M.I.1
Falk, G.2
Sten-Linder, M.3
Egberg, N.4
Blomback, M.5
Bremme, K.6
-
47
-
-
0030934739
-
Oral contraceptives and venous thrombosis; different sensitivities to activated protein C in women using second- and third generation oral contraceptives
-
Rosing J, Tans G, Nicolaes GAF, et al. Oral contraceptives and venous thrombosis; different sensitivities to activated protein C in women using second- and third generation oral contraceptives. Br J Haematol 1997; 97: 233-38.
-
(1997)
Br J Haematol
, vol.97
, pp. 233-238
-
-
Rosing, J.1
Tans, G.2
Nicolaes, G.A.F.3
|